Pharmaceutical Regulatory Affairs

Regulatory Affairs contributes essentially to the overall success of drug development, both at early pre-marketing stages and at all times post-marketing. The pharmaceutical industry deals with an increasing number of interesting drug candidates, all of which necessitate the involvement of the Regulatory Affairs’ department. Regulatory Affairs professionals can play a key role in guiding drug development strategy in an increasingly global environment. But they also play an important operational role, for example, by considering the best processes to follow and enabling structured interaction with regulatory authorities. Regulatory Affairs is driven by good science and accordingly nothing remains static.

The overall emerging markets for therapeutic drugs totaled $131.4 billion in 2009. These regions include Latin America, China, Eastern Europe, the Middle East, South Korea, India, Russia, and South Africa. These regions are estimated at $145.8 billion in 2010 and expected to continue aggressive growth through 2015, reaching a figure of $214.2 billion, yielding a compound annual growth rate (CAGR) of 8% from 2010 to 2015.

  • Regulatory & Pharmacovigilance
  • SOPs and Policy Documents
  • Clinical Affairs & Regulatory Strategies
  • Regulatory Strategies and Developments
  • Data Integrity towards Regulatory Affairs
  • Global Regulatory Intelligence
  • Regulatory Communications and Submissions
  • Regulatory Requirements for Pharmaceuticals
  • Medical Device & Combination Products Regulations
  • Best Industry Practices
  • Marketing Authorizations
  • Regulatory Challenges for Medical Devices
  • Food, drug and cosmetic laws
  • FDA and related regulatory agencies
  • Pharmacovigilance Regulations

Related Conference of Pharmaceutical Regulatory Affairs

February 24-25, 2025

2nd International Conference on Pharmacognosy

Madrid, Spain
February 27-28, 2025

8th International on Pharmacy and Pharmaceutical Conference

Prague, Czech Republic
March 10-11, 2025

35th Annual European Pharma Congress

Rome, Italy
April 14-15, 2025

18th European Biosimilars Congress

Paris, France
April 24-25, 2025

18th World Drug Delivery Summit

London, UK
May 05-06, 2025

19th World Drug Delivery Summit

Vancouver, Canada
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland
June 23-24, 2025

38th World Congress on Pharmacology

Aix-en-Provence, France
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland

Pharmaceutical Regulatory Affairs Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in